Turnover
≈ €240,000 estimated
The micro format states no turnover.
DD Pharma
Lifetime
1 annual account with figurespeak €22,999 (2025)
€22,999
peak €8,524 (2025)
€8,524
peak €11,524 (2025)
€11,524
€64,253
Board1 name since 2024
1 directorDRAOUI Dina
Documentsfilings and deeds
26-05-202626 days late
2025micro format
Purpose change 06-02First year with figures
Key points
from the 2025 annual accountsDebts
€64,253 85% of the balance sheet
Financial debts 37%Suppliers 10%Taxes and wages 18%Other 36%
Of this, €40,696 falls due within a year.
Starting capital
€3,000 100 shares
2025 accounts filed 26 days after the deadline
Checked score
64
Healthy
Financially stronger than 57% of micro companies in retail trade (NACE 47)
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
1.5% Moderate
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,277 companies (NACE 47, micro).
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2025: 1.8%
12-2025: 1.9%▲ +0.1 percentage points vs 11-2025
01-2026: 2.2%▲ +0.3 percentage points vs 12-2025
02-2026: 2.3%▲ +0.1 percentage points vs 01-2026
03-2026: 2.6%▲ +0.3 percentage points vs 02-2026
04-2026: 2.6%● unchanged vs 03-2026
05-2026: 2.9%▲ +0.3 percentage points vs 04-2026
06-2026: 3.0%▲ +0.1 percentage points vs 05-2026
07-2026: 2.8%▼ -0.2 percentage points vs 06-2026
08-2026: 2.9%▲ +0.1 percentage points vs 07-2026
09-2026: 3.2%▲ +0.3 percentage points vs 08-2026highest value
10-2026: 1.5%▼ -1.7 percentage points vs 09-2026lowest value
11-2026: 1.5%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Founded in 2024
Size: total assets €75,776
Equity €11,524 (15.2% of total assets)
lowers risk
Liquidity: current ratio 0.73, cash €21,199
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 31% of them on solvency, 64% on liquidity and 76% on profitability.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-09-2025.
Of the companies with a bankruptcy probability in the moderate class on 30-06-2025, 2.4% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 7,976 companies had the same profile as DD Pharma has now. Each dot stands for 20 companies, two years later.
94.3%
were still trading
1.8%
stopped another way
3.6%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of DD Pharma itself: 1.5% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,976 companies, not a prediction for DD Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.73, below 1. Short-term debt is 53.7% and cash 28% of total assets. 84.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 26 days late
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 26-05-2026, 26 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
26 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1014418872
Purpose change
“Aankoop, verkoop van stoffen, juwelen, kledij, schoenen zowel de verwerking en ontwerp van deze elementen in…” (deed in Dutch) · General meeting of 29-01-2025 · Gazette deed
Incorporation
Founding capital of €3,000, 100 shares · Founder: DRAOUI Dina · Appointment: DRAOUI Dina (director) · published on 03-10-2024 · Gazette deed
First establishment
Tervuursesteenweg 333, Leuven
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DD Pharma Leuven | €75,776 | €22,999 | 15.2% | - |
| ANA-AD Oud-Heverlee | €83,628 | €20,272 | 74.6% | - |
| TV Haacht | €65,446 | €28,856 | 79.4% | - |
| Apr. ZEYREK Leuven | €72,982 | €31,340 | 73.5% | - |
| Bossiroy Pharma Uccle | €65,695 | €27,817 | 91.4% | - |
| PHARMACIE PHARMISTE Brussels | €57,475 | €19,564 | 23.0% | - |
| A.CATRIN PHARMA Ham-sur-Heure-Nalinnes | €94,339 | €29,956 | 29.0% | - |
These companies have the same main activity as DD Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €57,500 and €94,300, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 01-10-2024Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.365.497.9233001 Leuven, since 01-10-2024
- Financial year end
- 30 September
- Peppol
- Reachable since 14-01-2026
Insights on DD Pharma
The computed 12-month bankruptcy probability of DD Pharma is 1.5% (moderate). The 2025 annual accounts show equity of €11,524 and a net result of €8,524.
Its solvency ranks better than 34% of 22,924 sector peers (NACE 47, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DD Pharma
- What is the company number of DD Pharma?
- The company number of DD Pharma is 1014.418.872. The VAT number is the same number with BE in front: BE 1014.418.872.
- Where is DD Pharma based?
- The registered office is at Tervuursesteenweg 333, 3001 Leuven.Company details
- What does DD Pharma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of DD Pharma?
- DD Pharma is a private limited company (BV).
- When was DD Pharma founded?
- DD Pharma was founded on 01-10-2024.
- Is DD Pharma still active?
- Yes, DD Pharma is an active enterprise in the KBO register.
- What is the turnover of DD Pharma?
- The turnover in financial year 2025 is ≈ €240,000. This figure is estimated from the gross margin of €22,999 and 118 comparable companies (NACE 477). It probably lies between €88,000 and €510,000. It is a rough estimate.Financials
- Is DD Pharma profitable?
- In financial year 2025, DD Pharma made a profit of €8,524.
- Where can I find the annual accounts of DD Pharma?
- DD Pharma filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.